环孢素用于表皮坏死松解症:174例患者暴露/非暴露及倾向性评分匹配分析中未见有益效应
这项2005—2016年单中心回顾性研究纳入174例史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者,其中95例接受环孢素(3 mg/kg/天)加支持治疗,79例仅支持治疗。采用传统暴露/非暴露及倾向性评分匹配法比较皮肤剥离进展、再上皮化起始、进展持续时间和死亡数,均未见显著有利于环孢素,且环孢素组急性肾衰竭更多(P=0.05)。
要点
- 环孢素3 mg/kg/天加支持治疗与仅支持治疗相比,各项结局均未见显著获益。
- 环孢素组急性肾衰竭患者更多(P=0.05)。
- 作者结论为环孢素在史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中未见有益效应,与既往发表结果不一致。
核心结论
- 这项流行病学研究结果未显示环孢素对史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者有益,与既往发表结果不一致。
研究设计与样本
- 2005—2016年单中心回顾性研究,纳入174例史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者,95例接受环孢素(3 mg/kg/天)加支持治疗,79例仅支持治疗。
- 采用传统暴露/非暴露法和倾向性评分匹配法进行比较。
主要发现
- 比较第0天至第5天皮肤剥离进展、第5天起皮肤再上皮化或第10天黏膜再上皮化的患者比例、进展持续时间和两组死亡数,均未见显著有利于环孢素。
- 接受环孢素的患者中急性肾衰竭更多(P = 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 主要局限性为缺乏随机化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cyclosporine has shown promising results for mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. However, available studies included only a small number of patients and did not include a validated and homogenous control group. We present the results from a retrospective monocentric study including 174 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis during 2005-2016. Among them, 95 received cyclosporine (3 mg/kg/day) plus supportive care, and 79 received supportive care only. Both a traditional exposed/unexposed method and a propensity score-matching method were used to compare the progression of skin detachment between day 0 and day 5, the proportion of patients with cutaneous re-epithelialization starting on day 5 or mucosal re-epithelialization on day 10, the duration of progression, and the number of deaths between the two groups. None of these outcomes significantly favored cyclosporine, either by the exposed/unexposed method or the propensity score method. Acute renal failure affected more patients receiving cyclosporine (P = 0.05). Overall, the results of this epidemiological study did not show a beneficial effect of cyclosporine in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. They are discordant with those previously published. The large number of patients and the use of a propensity score method provide valuable insights. The main limitation of the study is the lack of randomization.
引用
- Poizeau F, Gaudin O, Le Cleach L, et al. Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses. J Invest Dermatol. 2018. PMID: 29369774. doi:10.1016/j.jid.2017.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。